Baidu
map

肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

高血压肾病诊断和治疗中国专家共识（2022）

2022-04-20 高血压肾病诊治中国专家共识组成员 中华高血压杂志

高血压肾病

高血压肾病是我国常见的慢性肾脏病(CKD)之一,也是导致终末期肾病(ESRD)的重要病因。由于高血压肾病的发病率和死亡率逐年增加,临床对其规范诊治的需求较为迫切。但高血压肾病本身是一个交叉学科问题,并

中文标题：

高血压肾病诊断和治疗中国专家共识（2022）

发布机构：

高血压肾病诊治中国专家共识组成员

发布日期：

2022-04-20

简要介绍：

高血压肾病是我国常见的慢性肾脏病(CKD)之一,也是导致终末期肾病(ESRD)的重要病因。由于高血压肾病的发病率和死亡率逐年增加,临床对其规范诊治的需求较为迫切。但高血压肾病本身是一个交叉学科问题,并且高血压和原发性肾脏疾病的交互影响也对临床诊断和鉴别诊断提出了一定的挑战。如何明确高血压肾病的诊断,对高血压肾病患者实施CKD分阶式的生活指导、降压目标管理和药物治疗,以实现肾、心、脑等靶器官的保护具有极为重要的临床价值和现实意义。为此,由我国心血管和肾脏领域专家联合编写了这部《高血压肾病诊断和治疗中国专家共识(2022)》,对高血压肾病的诊断、病理特征、降压目标、生活管理与降压药治疗等问题提出建议。共识结合国内外高血压、高血压肾病及CKD血压管理等相关指南,梳理出有关高血压肾病的一些诊治指导意见,强调高血压肾病进展过程中不同CKD分期患者可能面临的治疗差异,同时也指出目前高血压肾病认知上存在的争议。本共识希望能为临床医师全面了解高血压肾病、有的放矢地进行患者诊治与管理、合理使用降压药等提供参考。

相关资料下载：
[AttachmentFileName(sort=1, fileName=高血压肾病诊断和治疗中国专家共识（2022）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=51d5b1c002a211f8, title=高血压肾病诊断和治疗中国专家共识（2022）, enTitle=, guiderFrom=中华高血压杂志, authorId=0, author=, summary=高血压肾病是我国常见的慢性肾脏病(CKD)之一,也是导致终末期肾病(ESRD)的重要病因。由于高血压肾病的发病率和死亡率逐年增加,临床对其规范诊治的需求较为迫切。但高血压肾病本身是一个交叉学科问题,并, cover=https://img.medsci.cn/20220426/1650957662816_5579292.jpg, journalId=0, articlesId=null, associationId=2649, associationName=高血压肾病诊治中国专家共识组成员, associationIntro=高血压肾病诊治中国专家共识组成员, copyright=0, guiderPublishedTime=Wed Apr 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">高血压肾病是我国常见的慢性肾脏病(CKD)之一,也是导致终末期肾病(ESRD)的重要病因。由于高血压肾病的发病率和死亡率逐年增加,临床对其规范诊治的需求较为迫切。但高血压肾病本身是一个交叉学科问题,并且高血压和原发性肾脏疾病的交互影响也对临床诊断和鉴别诊断提出了一定的挑战。如何明确高血压肾病的诊断,对高血压肾病患者实施CKD分阶式的生活指导、降压目标管理和药物治疗,以实现肾、心、脑等靶器官的保护具有极为重要的临床价值和现实意义。为此,由我国心血管和肾脏领域专家联合编写了这部《高血压肾病诊断和治疗中国专家共识(2022)》,对高血压肾病的诊断、病理特征、降压目标、生活管理与降压药治疗等问题提出建议。共识结合国内外高血压、高血压肾病及CKD血压管理等相关指南,梳理出有关高血压肾病的一些诊治指导意见,强调高血压肾病进展过程中不同CKD分期患者可能面临的治疗差异,同时也指出目前高血压肾病认知上存在的争议。本共识希望能为临床医师全面了解高血压肾病、有的放矢地进行患者诊治与管理、合理使用降压药等提供参考。</span></p>, tagList=[TagDto(tagId=22575, tagName=高血压肾病)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12011, appHits=501, showAppHits=0, pcHits=1597, showPcHits=11485, likes=3, shares=82, comments=13, approvalStatus=1, publishedTime=Tue Apr 26 15:14:11 CST 2022, publishedTimeString=2022-04-20, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Apr 26 15:16:22 CST 2022, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 16:09:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高血压肾病诊断和治疗中国专家共识（2022）.pdf)])
高血压肾病诊断和治疗中国专家共识（2022）.pdf
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2089435, encodeId=55362089435e6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c46c5197630, createdName=1472d9b8m50暂无昵称, createdTime=Tue Sep 20 23:24:55 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232065, encodeId=9c4f123206517, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/17/43f4b3da2ebf9a396e501c39c1357036.jpg, createdBy=670c5197562, createdName=nana-C, createdTime=Tue Jul 12 20:06:13 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221327, encodeId=9296122132ed6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220424/d1a02915c1074376b5d24f9bebd99767/33e8a532f6b94a6b8cef81d5e81e391b.jpg, createdBy=5ef76425265, createdName=2022.4, createdTime=Sat May 21 06:02:49 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218583, encodeId=c323121858351, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:13:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215567, encodeId=16e0121556e97, content=学习中，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecf2827784, createdName=sxlyj99, createdTime=Fri Apr 29 11:58:04 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-09-20 1472d9b8m50暂无昵称

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2089435, encodeId=55362089435e6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c46c5197630, createdName=1472d9b8m50暂无昵称, createdTime=Tue Sep 20 23:24:55 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232065, encodeId=9c4f123206517, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/17/43f4b3da2ebf9a396e501c39c1357036.jpg, createdBy=670c5197562, createdName=nana-C, createdTime=Tue Jul 12 20:06:13 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221327, encodeId=9296122132ed6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220424/d1a02915c1074376b5d24f9bebd99767/33e8a532f6b94a6b8cef81d5e81e391b.jpg, createdBy=5ef76425265, createdName=2022.4, createdTime=Sat May 21 06:02:49 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218583, encodeId=c323121858351, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:13:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215567, encodeId=16e0121556e97, content=学习中，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecf2827784, createdName=sxlyj99, createdTime=Fri Apr 29 11:58:04 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-07-12 nana-C

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2089435, encodeId=55362089435e6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c46c5197630, createdName=1472d9b8m50暂无昵称, createdTime=Tue Sep 20 23:24:55 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232065, encodeId=9c4f123206517, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/17/43f4b3da2ebf9a396e501c39c1357036.jpg, createdBy=670c5197562, createdName=nana-C, createdTime=Tue Jul 12 20:06:13 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221327, encodeId=9296122132ed6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220424/d1a02915c1074376b5d24f9bebd99767/33e8a532f6b94a6b8cef81d5e81e391b.jpg, createdBy=5ef76425265, createdName=2022.4, createdTime=Sat May 21 06:02:49 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218583, encodeId=c323121858351, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:13:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215567, encodeId=16e0121556e97, content=学习中，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecf2827784, createdName=sxlyj99, createdTime=Fri Apr 29 11:58:04 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-05-21 2022.4

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2089435, encodeId=55362089435e6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c46c5197630, createdName=1472d9b8m50暂无昵称, createdTime=Tue Sep 20 23:24:55 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232065, encodeId=9c4f123206517, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/17/43f4b3da2ebf9a396e501c39c1357036.jpg, createdBy=670c5197562, createdName=nana-C, createdTime=Tue Jul 12 20:06:13 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221327, encodeId=9296122132ed6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220424/d1a02915c1074376b5d24f9bebd99767/33e8a532f6b94a6b8cef81d5e81e391b.jpg, createdBy=5ef76425265, createdName=2022.4, createdTime=Sat May 21 06:02:49 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218583, encodeId=c323121858351, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:13:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215567, encodeId=16e0121556e97, content=学习中，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecf2827784, createdName=sxlyj99, createdTime=Fri Apr 29 11:58:04 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-05-10 ms9000000231852747

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2089435, encodeId=55362089435e6, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c46c5197630, createdName=1472d9b8m50暂无昵称, createdTime=Tue Sep 20 23:24:55 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232065, encodeId=9c4f123206517, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/17/43f4b3da2ebf9a396e501c39c1357036.jpg, createdBy=670c5197562, createdName=nana-C, createdTime=Tue Jul 12 20:06:13 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221327, encodeId=9296122132ed6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220424/d1a02915c1074376b5d24f9bebd99767/33e8a532f6b94a6b8cef81d5e81e391b.jpg, createdBy=5ef76425265, createdName=2022.4, createdTime=Sat May 21 06:02:49 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218583, encodeId=c323121858351, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:13:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215567, encodeId=16e0121556e97, content=学习中，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ecf2827784, createdName=sxlyj99, createdTime=Fri Apr 29 11:58:04 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-04-29 sxlyj99

    学习中，多谢

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map